Overview
Case Challenges in IPF: Integrating Respiratory Care into Comprehensive Care Plans
Breakfast Symposium & Live Streaming Opportunity held in conjunction with the AARC Congress 2018.
Registration is closed for this activity.
This live symposium will feature two expert faculty members, who will present case challenges, consider common and unanswered questions and illustrate potential outcomes with different approaches to IPF patient management. Discussion topics will include: accurate diagnosis of IPF, selection of pharmacotherapy, and formulating respiratory care plans for IPF patients.
For those unable to attend AARC Congress 2018, please register to stream the live session on December 6th to your personal device.
For those unable to attend AARC Congress 2018, please register to stream the live session on December 6th to your personal device.
This educational activity is designed for attendees of the AARC Congress, respiratory therapists, and other clinicians involved in the management of patients with IPF.
Idiopathic pulmonary fibrosis (IPF) is a rare, progressive lung disease that greatly impacts patients’ quality of life and diminishes life expectancy. Therapies are available that slow lung function decline. These therapies are used in combination with oxygen supplementation, pulmonary rehabilitation, symptomatic treatment, and supportive care. Respiratory therapists need education on therapies and supportive care to educate and counsel patients with IPF, as well as optimize their care.
Upon completion of this activity, participants will be able to:
• Describe identifying risk factors for IPF, its incidence, and characteristics of its disease course
• Discuss the roles of available pharmacotherapies and pulmonary rehabilitation programs in the management of IPF disease progression, comorbidities, and symptoms
• Formulate comprehensive care plans to improve IPF patients’ quality of life and activities of daily living
• Counsel IPF patients and their caregivers on key aspects of IPF from diagnosis to treatment
• Describe identifying risk factors for IPF, its incidence, and characteristics of its disease course
• Discuss the roles of available pharmacotherapies and pulmonary rehabilitation programs in the management of IPF disease progression, comorbidities, and symptoms
• Formulate comprehensive care plans to improve IPF patients’ quality of life and activities of daily living
• Counsel IPF patients and their caregivers on key aspects of IPF from diagnosis to treatment
Sponsored by the Academy for Continued Healthcare Learning (ACHL).
Supported by educational grants from Boehringer Ingelheim Pharmaceuticals, Inc. and Genentech, Inc.
Learners who are unable to attend the symposium in the traditional setting will have the opportunity to log-in on any device to watch the activity live. These learners will have the same experience as traditional attendees as they will see the faculty, slides, will be able to participate in the pre-/post-test polling, and will receive credit for their participation. Furthermore, learners will be able to pose questions to the faculty which will be addressed at the end of the symposium.
For live streaming participants, please click the following link to view this session from your home or office, and receive CRCE credit:
https://virtual.arraylearn.com/activity_files/4ed7012c-f30a-11e8-9d63-005056011b62/virtual/landing.html
For live streaming participants, please click the following link to view this session from your home or office, and receive CRCE credit:
https://virtual.arraylearn.com/activity_files/4ed7012c-f30a-11e8-9d63-005056011b62/virtual/landing.html
Imre Noth, MD
Professor of Medicine
University of Virginia School of Medicine
Division Chief, Pulmonary and Critical Care Medicine
University of Virginia Health Systems
Charlottesville, VA
Professor of Medicine
University of Virginia School of Medicine
Division Chief, Pulmonary and Critical Care Medicine
University of Virginia Health Systems
Charlottesville, VA
Trina Limberg, BS, RRT, FAARC, MAACVPR
Director, Pulmonary Rehabilitation Services
UC San Diego Health System
San Diego, CA
To receive credit, participants are required to participate in the live activity and complete the posttest and evaluation utilizing the ARRAY™ Tablet app. Certificates will be emailed within two weeks. There is no fee to participate in the activity or for the generation of the certificate.
Continued Respiratory Care Education (CRCE) has been requested for this session through the American Association for Respiratory Care (AARC).